Used in research to inhibit insulin-like growth factor-1 receptor (IGF-1R) signaling, which plays a role in cancer cell proliferation and survival. Shows potential in studies targeting tumor growth, particularly in cancers dependent on IGF-1R pathways such as lung, breast, and sarcoma. Often applied in preclinical models to evaluate antitumor efficacy and combination therapies with other anticancer agents.